Express Pharma

Torrent Pharma Q4 net up 11% at ₹ 228 crore

5

Revenues for the fourth quarter rose to ₹ 1,722 crore

Torrent Pharmaceuticals posted 11 per cent increase in consolidated net profit at 228 crore for the fourth quarter ended March 2018, driven by robust sales in domestic market.

The company had reported a net profit of 206 crore during the same period last year. Revenues for the fourth quarter rose to 1,722 crore, as compared with 1,434 crore in the January March period of 2016-17, Torrent Pharmaceuticals said in a regulatory filing. For the year ended March 31, 2018, the company posted a net profit of 678 crore, down 27 per cent from 934 crore in 2016-17.Revenues during the year, however, rose by 2 per cent to Rs 6,002 crore, compared with 5,857 crore in 2016-17.

During the year ended March 31, 2018, the company said its revenues in the domestic market grew by 19 per cent to 2,351 crore, as against 1,976 crore in 2016-17. In the US market, the company said its revenues declined to 1,100 crore in 2017-18 as compared with 1,346 crore in 2016-17. The company’s board recommended a final dividend of 5 per equity share of face value of 5 each.

 

 

Comments are closed.